| Literature DB >> 21478023 |
L W Wang1, S J Wang, P Y Chu, C Y Ho, S H Jiang, Y W H Liu, Y H Liu, H M Liu, J J Peir, F I Chou, S H Yen, Y L Lee, C W Chang, C S Liu, Y W Chen, K Ono.
Abstract
To introduce our preliminary experience of treating locally and regionally recurrent Head and Neck cancer patients at Tsing Hua Open-Pool Reactor in Taiwan, four patients (M/F=3/1, median age 68 Y/O) were enrolled. BNCT with BPA (400 mg/kg) injected in 2 phases and prescription dose of 12-35 Gy (Eq.)/fraction for 2 fractions at 30 day interval can be given with sustained blood boron concentration and tolerable early toxicities for recurrent H & N cancer. Copyright ÂEntities:
Mesh：
Year: 2011 PMID： 21478023 DOI： 10.1016/j.apradiso.2011.03.008
Source DB: PubMed Journal: Appl Radiat Isot ISSN： 0969-8043 Impact factor: 1.513